{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T03:19:46Z","timestamp":1764645586704,"version":"build-2065373602"},"reference-count":67,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"South African National Research Foundation","award":["118022 and 120383"],"award-info":[{"award-number":["118022 and 120383"]}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","award":["Extramural unit baseline funding"],"award-info":[{"award-number":["Extramural unit baseline funding"]}],"id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The paucity of animal models that simulate the replication of the hepatitis B virus (HBV) is an impediment to advancing new anti-viral treatments. The work reported here employed recombinant adeno-associated viruses (AAVs) to model HBV subgenotype A1 and subgenotype D3 replication in vitro and in vivo. Infection with subgenotype A1 is endemic to parts of sub-Saharan Africa, and it is associated with a high risk of hepatocellular carcinoma. Recombinant AAV serotype 2 (AAV2) and 8 (AAV8) vectors bearing greater-than-genome-length sequences of HBV DNA from subgenotype A1 and D3, were produced. Transduced liver-derived cultured cells produced HBV surface antigen and core antigen. Administration of AAV8 carrying HBV subgenotype A1 genome (AAV8-A1) to mice resulted in the sustained production of HBV replication markers over a six-month period, without elevated inflammatory cytokines, expression of interferon response genes or alanine transaminase activity. Markers of replication were generally higher in animals treated with subgenotype D3 genome-bearing AAVs than in those receiving the subgenotype A1-genome-bearing vectors. To validate the use of the AAV8-A1 murine model for anti-HBV drug development, the efficacy of anti-HBV artificial primary-microRNAs was assessed. Significant silencing of HBV markers was observed over a 6-month period after administering AAVs. These data indicate that AAVs conveniently and safely recapitulate the replication of different HBV subgenotypes, and the vectors may be used to assess antivirals\u2019 potency.<\/jats:p>","DOI":"10.3390\/v13112247","type":"journal-article","created":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T21:39:07Z","timestamp":1636493947000},"page":"2247","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors"],"prefix":"10.3390","volume":"13","author":[{"given":"Shonisani Wendy","family":"Limani","sequence":"first","affiliation":[{"name":"Wits\/SAMRC Antiviral Gene Therapy Research Unit, Health Sciences Faculty, School of Pathology, University of the Witwatersrand, Private Bag 3, WITS 2050, Johannesburg 2000, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Njabulo","family":"Mnyandu","sequence":"additional","affiliation":[{"name":"Wits\/SAMRC Antiviral Gene Therapy Research Unit, Health Sciences Faculty, School of Pathology, University of the Witwatersrand, Private Bag 3, WITS 2050, Johannesburg 2000, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Ely","sequence":"additional","affiliation":[{"name":"Wits\/SAMRC Antiviral Gene Therapy Research Unit, Health Sciences Faculty, School of Pathology, University of the Witwatersrand, Private Bag 3, WITS 2050, Johannesburg 2000, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5981-4450","authenticated-orcid":false,"given":"Reubina","family":"Wadee","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Health Sciences Faculty, School of Pathology, University of the Witwatersrand, Private Bag 3, WITS 2050 and National Health Laboratory Services, P.O. Box 1038, Johannesburg 2000, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6006-3765","authenticated-orcid":false,"given":"Anna","family":"Kramvis","sequence":"additional","affiliation":[{"name":"Hepatitis Virus Diversity Research Unit, Health Sciences Faculty, School of Clinical Medicine, University of the Witwatersrand, Private Bag 3, WITS 2050, Johannesburg 2000, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4149-8995","authenticated-orcid":false,"given":"Patrick","family":"Arbuthnot","sequence":"additional","affiliation":[{"name":"Wits\/SAMRC Antiviral Gene Therapy Research Unit, Health Sciences Faculty, School of Pathology, University of the Witwatersrand, Private Bag 3, WITS 2050, Johannesburg 2000, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohube Betty","family":"Maepa","sequence":"additional","affiliation":[{"name":"Wits\/SAMRC Antiviral Gene Therapy Research Unit, Health Sciences Faculty, School of Pathology, University of the Witwatersrand, Private Bag 3, WITS 2050, Johannesburg 2000, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jmv.21774","article-title":"Hepatitis B virus BCP, Precore\/core, X gene mutations\/genotypes and the risk of hepatocellular carcinoma in India","volume":"82","author":"Asim","year":"2010","journal-title":"J. Med. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bpg.2017.04.013","article-title":"The virological aspects of hepatitis B","volume":"31","author":"Valaydon","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrgastro.2016.7","article-title":"Global strategies are required to cure and eliminate HBV infection","volume":"13","author":"Revill","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","unstructured":"WHO (2021). Interim Guidance for Country Validation of Viral Hepatitis Elimination, WHO."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000360947","article-title":"Genotypes and genetic variability of hepatitis B virus","volume":"57","author":"Kramvis","year":"2014","journal-title":"Intervirology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7196\/SAMJ.8607","article-title":"Preventing hepatitis B and hepatocellular carcinoma in South Africa: The case for a birth-dose vaccine","volume":"104","author":"Spearman","year":"2014","journal-title":"SAMJ S. Afr. Med. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1099\/vir.0.19749-0","article-title":"Distinctive sequence characteristics of subgenotype A1 isolates of hepatitis B virus from South Africa","volume":"85","author":"Kimbi","year":"2004","journal-title":"J. Gen. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/jmv.20311","article-title":"Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans","volume":"75","author":"Kew","year":"2005","journal-title":"J. Med. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3851\/IMP2657","article-title":"Subgenotype A1 of HBV\u2014Tracing human migrations in and out of Africa","volume":"18","author":"Kramvis","year":"2013","journal-title":"Antivir. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.vaccine.2004.10.045","article-title":"Hepatitis B virus genotypes","volume":"23","author":"Kramvis","year":"2005","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"i18","DOI":"10.1136\/gutjnl-2012-302085","article-title":"New perspectives in the therapy of chronic hepatitis B","volume":"61","author":"Lampertico","year":"2012","journal-title":"Gut"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2012.01.044","article-title":"Effectiveness of hepatitis B treatment in clinical practice","volume":"142","author":"Scaglione","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Colagrossi, L., Hermans, L.E., Salpini, R., Di Carlo, D., Pas, S.D., Alvarez, M., Ben-Ari, Z., Boland, G., Bruzzone, B., and Coppola, N. (2018). Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe. BMC Infect. Dis., 18.","DOI":"10.1186\/s12879-018-3161-2"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17589","DOI":"10.3390\/ijms160817589","article-title":"Progress and prospects of anti-HBV gene therapy development","volume":"16","author":"Maepa","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Bloom, K., Maepa, M.B., Ely, A., and Arbuthnot, P. (2018). Gene Therapy for Chronic HBV\u2014Can We Eliminate cccDNA?. Genes, 9.","DOI":"10.3390\/genes9040207"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-017-01953-y","article-title":"Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques","volume":"8","author":"Burwitz","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/pathogens3020377","article-title":"Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions","volume":"3","author":"Inuzuka","year":"2014","journal-title":"Pathogens"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2893.2010.01302.x","article-title":"Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B","volume":"18","author":"Untergasser","year":"2011","journal-title":"J. Viral Hepat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1128\/JVI.75.11.5108-5118.2001","article-title":"Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: Crossing the species barrier","volume":"75","author":"Sprinzl","year":"2001","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1053\/j.gastro.2012.03.006","article-title":"Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice","volume":"142","author":"Huang","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_22","first-page":"1511","article-title":"A murine model of hepatitis B-associated hepatocellular carcinoma generated by adeno-associated virus-mediated gene delivery","volume":"39","author":"Huang","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/cmi.2013.43","article-title":"A mouse model for HBV immunotolerance and immunotherapy","volume":"11","author":"Yang","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ye, L., Yu, H., Li, C., Hirsch, M.L., Zhang, L., Samulski, R.J., Li, W., and Liu, Z. (2015). Adeno-associated virus vector mediated delivery of the HBV genome induces chronic hepatitis B virus infection and liver fibrosis in mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130052"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhang, Y.L., Cheng, T., Cai, Y.J., Yuan, Q., Liu, C., Zhang, T., Xia, D.Z., Li, R.Y., Yang, L.W., and Wang, Y.B. (2010). RNA Interference inhibits hepatitis B virus of different genotypes in vitro and in vivo. BMC Microbiol., 10.","DOI":"10.1186\/1471-2180-10-214"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jviromet.2014.03.015","article-title":"Construction of replication competent plasmids of hepatitis B virus subgenotypes A1, A2 and D3 with authentic endogenous promoters","volume":"203","author":"Bhoola","year":"2014","journal-title":"J. Virol. Methods"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/jvi.66.7.4107-4116.1992","article-title":"The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly","volume":"66","author":"Nassal","year":"1992","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.omtn.2017.04.007","article-title":"Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs","volume":"7","author":"Maepa","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jviromet.2016.05.008","article-title":"Successful disabling of the 5\u2032 UTR of HCV using adeno-associated viral vectors to deliver modular multimeric primary microRNA mimics","volume":"235","author":"Bourhill","year":"2016","journal-title":"J. Virol. Methods"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature04791","article-title":"Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways","volume":"441","author":"Grimm","year":"2006","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Crowther, C., Mowa, B., and Arbuthnot, P. (2016). Hepatic delivery of artificial micro RNAs using helper-dependent adenoviral vectors. SiRNA Delivery Methods, Springer Nature.","DOI":"10.1007\/978-1-4939-3112-5_20"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Bloom, K., Kaldine, H., Cathomen, T., Mussolino, C., Ely, A., and Arbuthnot, P. (2019). Inhibition of replication of hepatitis B virus using transcriptional repressors that target the viral DNA. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-4436-y"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Moore, D.D., and Dowhan, D. (2002). Preparation and Analysis of DNA. Current Protocols in Molecular Biology, Wiley Online Library.","DOI":"10.1002\/0471142727.mb0200s58"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1172\/JCI43565","article-title":"Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver","volume":"120","author":"Grimm","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2893.2005.00624.x","article-title":"Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy","volume":"12","author":"Kramvis","year":"2005","journal-title":"J. Viral Hepat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20365","article-title":"A case-control study for differences among hepatitis B virus infections of genotypes A (subtypes Aa and Ae) and D","volume":"40","author":"Tanaka","year":"2004","journal-title":"Hepatology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virol.2019.11.001","article-title":"Analysis of the in vitro replication phenotype of African hepatitis B virus (HBV) genotypes and subgenotypes present in Australia identifies marked differences in DNA and protein expression","volume":"540","author":"Bannister","year":"2020","journal-title":"Virology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000446240","article-title":"Hepatitis B e Antigen Expression by Hepatitis B Virus Subgenotype A1 Relative to Subgenotypes A2 and D3 in Cultured Hepatocellular Carcinoma (Huh7) Cells","volume":"59","author":"Bhoola","year":"2016","journal-title":"Intervirology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","article-title":"Human Immune Responses to Adeno-Associated Virus (AAV) Vectors","volume":"11","author":"Ronzitti","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_43","first-page":"6459","article-title":"The genome of self-complementary adeno-associated viral vectors increases Toll-like receptor 9\u2013dependent innate immune responses in the liver. Blood","volume":"117","author":"Martino","year":"2011","journal-title":"J. Am. Soc. Hematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","article-title":"The neurotropic properties of AAV-PHP. B are limited to C57BL\/6J mice","volume":"26","author":"Hordeaux","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9849","DOI":"10.1073\/pnas.1730940100","article-title":"Nuclear import of hepatitis B virus capsids and release of the viral genome","volume":"100","author":"Rabe","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1099\/vir.0.064816-0","article-title":"Expression of viral polymerase and phosphorylation of core protein determine core and capsid localization of the human hepatitis B virus","volume":"96","author":"Deroubaix","year":"2015","journal-title":"J. Gen. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(03)00031-X","article-title":"The effects of hepatitis B virus core promoter mutations on hepatitis B core antigen distribution in hepatocytes as detected by laser-assisted microdissection","volume":"38","author":"Kawai","year":"2003","journal-title":"J. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1086\/382190","article-title":"Intracellular distribution of hepatitis B virus core protein expressed in vitro depends on the sequence of the isolate and the serologic pattern","volume":"189","author":"Jazayeri","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jmv.21049","article-title":"Relationship of serological subtype, basic core promoter and precore mutations to genotypes\/subgenotypes of hepatitis B virus","volume":"80","author":"Kramvis","year":"2008","journal-title":"J. Med. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Li, H.C., Huang, E.Y., Su, P.Y., Wu, S.Y., Yang, C.C., Lin, Y.S., Chang, W.C., and Shih, C. (2010). Nuclear export and import of human hepatitis B virus capsid protein and particles. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001162"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6459","DOI":"10.1073\/pnas.90.14.6459","article-title":"Cell cycle regulation of nuclear localization of hepatitis B virus core protein","volume":"90","author":"Yeh","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/0016-5085(95)90760-2","article-title":"Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B","volume":"109","author":"Chu","year":"1995","journal-title":"Gastroenterology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0016-5085(87)90863-8","article-title":"Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic\/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis","volume":"92","author":"Chu","year":"1987","journal-title":"Gastroenterology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0168-8278(87)80060-0","article-title":"Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection","volume":"5","author":"Hsu","year":"1987","journal-title":"J. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.antiviral.2017.07.006","article-title":"Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector","volume":"145","author":"Lucifora","year":"2017","journal-title":"Antiviral Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"105140","DOI":"10.1016\/j.antiviral.2021.105140","article-title":"Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors","volume":"194","author":"Ko","year":"2021","journal-title":"Antiviral Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.1128\/JVI.03134-12","article-title":"Adeno-associated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLA-DR1 molecules","volume":"87","author":"Dion","year":"2013","journal-title":"J. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-cell exhaustion in chronic infections: Reversing the state of exhaustion and reinvigorating optimal protective immune responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1172\/JCI79213","article-title":"Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy","volume":"125","author":"Chandler","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ng.3893","article-title":"Identification of liver-specific enhancer-promoter activity in the 3\u2019 untranslated region of the wild-type AAV2 genome","volume":"49","author":"Logan","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3389","article-title":"Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas","volume":"47","author":"Nault","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.31557\/APJCP.2019.20.8.2239","article-title":"Association between Hepatitis B Surface Antigen Levels and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection: Systematic Review and Meta-Analysis","volume":"20","author":"Vo","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/nar\/gkp446","article-title":"Efficient silencing of gene expression with modular trimeric Pol II expression cassettes comprising microRNA shuttles","volume":"37","author":"Ely","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/mt.2008.82","article-title":"Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo","volume":"16","author":"Ely","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jhep.2009.10.038","article-title":"Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sites","volume":"52","author":"Sun","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsiere","year":"2016","journal-title":"Nature"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/11\/2247\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:28:03Z","timestamp":1760167683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/11\/2247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,9]]},"references-count":67,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["v13112247"],"URL":"https:\/\/doi.org\/10.3390\/v13112247","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2021,11,9]]}}}